HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ken-Ichi Watanabe Selected Research

Breast Neoplasms (Breast Cancer)

10/2023Patients Offer Radiofrequency Ablation Therapy for Early Breast Cancer as Local Therapy (PO-RAFAELO) Study under the Patient-proposed Health Services.
10/2021A Correlation Analysis Between Metabolism-related Genes and Treatment Response to S-1 as First-line Chemotherapy for Metastatic Breast Cancer: The SELECT BC-EURECA Study.
4/2021Oral care and oral assessment guide in breast cancer patients receiving everolimus and exemestane: subanalysis of a randomized controlled trial (Oral Care-BC).
4/2021Prospective cohort study of febrile neutropenia in breast cancer patients administered with neoadjuvant and adjuvant chemotherapies: CSPOR-BC FN study.
1/2021Secondary endpoints analysis in patients with estrogen receptor-positive metastatic breast cancer treated with everolimus and exemestane enrolled in Oral Care-BC.
1/2020Oral Care Evaluation to Prevent Oral Mucositis in Estrogen Receptor-Positive Metastatic Breast Cancer Patients Treated with Everolimus (Oral Care-BC): A Randomized Controlled Phase III Trial.
7/2018Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).
11/2017Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancer.
9/2016Evaluation of oral care to prevent oral mucositis in estrogen receptor-positive metastatic breast cancer patients treated with everolimus (Oral Care-BC): randomized controlled phase III trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ken-Ichi Watanabe Research Topics

Disease

12Neoplasms (Cancer)
09/2023 - 07/2006
9Breast Neoplasms (Breast Cancer)
10/2023 - 09/2016
4Infections
07/2022 - 09/2011
4Stomatitis
04/2021 - 09/2016
3Enzootic Bovine Leukosis (Bovine Leukosis)
04/2024 - 06/2021
3Triple Negative Breast Neoplasms
07/2023 - 01/2018
2Mucositis
04/2021 - 01/2020
2Inflammation (Inflammations)
02/2018 - 01/2016
2Amyloidosis
02/2018 - 09/2011
2Neuroblastoma
11/2005 - 10/2005
1Facial Paralysis (Facial Palsy)
05/2024
1Neglected Diseases
12/2023
1Schistosomiasis (Bilharziasis)
12/2023
1Hemangiosarcoma (Angiosarcoma)
09/2023
1Carcinogenesis
09/2023
1Lymphatic Metastasis
05/2023
1African Trypanosomiasis (Nagana)
03/2022
1Chagas Disease (American Trypanosomiasis)
03/2022
1Urinary Tract Infections (Urinary Tract Infection)
03/2022
1Acute Myelomonocytic Leukemia
10/2021
1Lymphoma (Lymphomas)
10/2021
1Leukemia
10/2021
1Chronic Limb-Threatening Ischemia
09/2021
1Febrile Neutropenia
04/2021
1Neutropenia
04/2021
1IGA Glomerulonephritis (IGA Nephropathy)
01/2021
1Medulloblastoma
10/2020
1Anemia
07/2020
1Stroke (Strokes)
05/2020
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2020
1Metaplasia
01/2020
1Carcinoma (Carcinomatosis)
01/2020
1Cholecystitis
01/2020
1Adenoma (Adenomas)
01/2020
1Hyperplasia
01/2020
1Adenocarcinoma
01/2020
1Peripheral Arterial Occlusive Disease 1
06/2019
1Necrosis
07/2018
1Edema (Dropsy)
07/2018

Drug/Important Bio-Agent (IBA)

5Estrogen ReceptorsIBA
10/2021 - 09/2016
4DNA (Deoxyribonucleic Acid)IBA
04/2024 - 02/2018
4Biomarkers (Surrogate Marker)IBA
09/2023 - 01/2020
4exemestane (Aromasin)FDA Link
04/2021 - 09/2016
4EverolimusFDA Link
04/2021 - 09/2016
3Immune Checkpoint InhibitorsIBA
05/2023 - 11/2017
3Cisplatin (Platino)FDA LinkGeneric
11/2005 - 11/2002
2Cell-Free Nucleic AcidsIBA
09/2023 - 01/2020
2LigandsIBA
07/2023 - 05/2023
2taxaneIBA
10/2021 - 07/2018
2Dexamethasone (Maxidex)FDA LinkGeneric
04/2021 - 01/2020
2AA amyloidosisIBA
02/2018 - 09/2011
2Proteins (Proteins, Gene)FDA Link
11/2005 - 10/2005
1Praziquantel (Biltricide)FDA Link
12/2023
1Tumor Biomarkers (Tumor Markers)IBA
09/2023
1AntigensIBA
07/2022
1BoLA-DRB3 antigenIBA
07/2022
1Nitrofurantoin (Macrodantin)FDA LinkGeneric
03/2022
1NifurtimoxIBA
03/2022
1Naphthol AS D Esterase (ANAE)IBA
10/2021
1Coloring Agents (Dyes)IBA
10/2021
1TubulinIBA
10/2021
1Formaldehyde (Formol)FDA Link
10/2021
1Epidermal Growth Factor (EGF)IBA
10/2021
1Progesterone Receptors (Progesterone Receptor)IBA
10/2021
1pyrimidineIBA
10/2021
1ParaffinIBA
10/2021
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
06/2021
1Bone Morphogenetic Protein 6IBA
06/2021
1Ointments (Pastes)IBA
04/2021
1pegfilgrastim (Neulasta)FDA Link
04/2021
1Benzethonium (Magic, Formula)IBA
04/2021
1Anti-Bacterial Agents (Antibiotics)IBA
04/2021
116S Ribosomal RNAIBA
01/2021
1Phosphopyruvate Hydratase (Enolase)IBA
10/2020
1Itraconazole (Sporanox)FDA LinkGeneric
09/2020
1Cytarabine (Cytosar-U)FDA LinkGeneric
07/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
07/2020
1Prednisolone (Predate)FDA LinkGeneric
07/2020
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
01/2020
1Circulating Tumor DNAIBA
01/2020
1MucinsIBA
01/2020
1Keratin-19 (Keratin 19)IBA
01/2020
1Alcian BlueIBA
01/2020
1Periodic AcidIBA
01/2020
1Hormones (Hormone)IBA
01/2020
1Keratins (Keratin)IBA
01/2020
1FibrinIBA
07/2018
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
07/2018

Therapy/Procedure

5Drug Therapy (Chemotherapy)
05/2024 - 07/2018
5Therapeutics
10/2023 - 07/2018
1Mass Drug Administration
12/2023
1Radiofrequency Ablation
10/2023
1Surgical Amputation (Amputations)
09/2021
1Dentures
04/2021
1Radiotherapy
04/2021
1Oral Administration
09/2020
1Blood Transfusion (Blood Transfusions)
07/2020
1Thrombectomy
05/2020
1Drug Tapering
01/2020
1Endarterectomy (Thromboendarterectomy)
06/2019